Currently, the drug market in Iran is facing serious challenges. Sanctions and currency restrictions, along with diplomatic and budgetary issues, have jeopardized the future of public health, and it seems that the depth of this crisis is increasing day by day.
Pressure on Drug Production and Access
In recent weeks, concerning news about shortages of essential medicines has emerged. Medicines that faced distribution and supply issues even in normal conditions are now on the brink of a serious crisis. This situation not only negatively impacts patients but also harms the country's pharmaceutical industries.
It is predicted that if this situation continues, we will witness an increase in drug prices and consequently, many people will be unable to secure the necessary medications. Many families are currently struggling to provide vital medicines for their loved ones. This crisis could lead to increased pressure on the country's healthcare system and ultimately affect public health.
Diplomatic and Economic Challenges
It seems that the impacts of sanctions are not limited to economic issues but have also cast a shadow over the country's diplomacy. In such circumstances, efforts to improve international relations and remove currency barriers have become one of the fundamental priorities. But will these efforts yield results?
Ultimately, the drug crisis in Iran has become a serious problem and requires urgent fundamental and effective actions. Otherwise, we should expect more severe consequences in the not-so-distant future. If the government and relevant institutions do not respond quickly to these challenges, we may witness a deeper crisis in the drug market and consequently, the public health of the country.
